BMOV

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameBMOV

Drug Alias NameBMOVVO(ma)2bis(maltolato)oxavanadium(IV)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInsulin sensitizers

TargetsNot applicable

Therapy Area/IndicationsBurns

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCfm Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCfm Pharma

Active IndicationsN/A

Inactive IndicationsBurns

ATC CodeN/A